Javascript must be enabled for the correct page display
Skip to Content
navigation opener
In the News

๐—•๐—ผ๐—ฟ๐—ฎ ๐—•๐—ถ๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฐ๐˜€ ๐—”๐—ฝ๐—ฝ๐—ผ๐—ถ๐—ป๐˜๐˜€ ๐—๐—ฒ๐—ป๐—ป๐—ถ๐—ณ๐—ฒ๐—ฟ ๐—ž๐˜‚๐—ฎ๐—ป ๐—ฎ๐˜€ ๐—–๐—ต๐—ถ๐—ฒ๐—ณ ๐—˜๐˜…๐—ฒ๐—ฐ๐˜‚๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ข๐—ณ๐—ณ๐—ถ๐—ฐ๐—ฒ๐—ฟ

Bora Biologics is pleased to announce the appointment of Jennifer Kuan as Chief Executive Officer.

Jennifer brings deep leadership experience across biologics, CDMO operations, customer partnerships, and organizational growth. As CEO, she will lead Bora Biologics into its next phase of development, building on the companyโ€™s strong foundation in scientific excellence, operational quality, and customer-focused biologics manufacturing.

Under Jenniferโ€™s leadership, Bora Biologics will continue to strengthen its global capabilities, support customers from development through commercialization, and advance its mission to help bring life-changing biologics to patients around the world.

Filter

Bora Biologics

the logical choice

Join the ranks of biopharma pioneers who trust us.
Explore how we minimize risks and accelerate your success.

Partner with us

Client-Centric

100% commitment to supporting your success

We have been the client, bringing multiple biologics from IND to BLA. Your needs and goals are at the forefront of our approach. By involving you in every step of the process, we ensure transparency and alignment, reducing the likelihood of misunderstandings and ensuring the outcome meets your expectations.

Experience

15+ years developing & manufacturing biologics

We have honed our ability to navigate complexities. Our track record from concept to commercialization means we can apply best practices and lessons learned, ensuring smoother project execution.

Expertise

Over 200 seasoned scientists & regulatory professionals

Our team exudes deep knowledge and specialized skills. This expertise allows us to foresee potential challenges and implement proactive solutions, reducing the likelihood of setbacks.

Commercial-Ready

2 US FDA registered GMP manufacturing facilities

We focus on delivering solutions that are ready for market. With clinical to commercial scale facilities consistently meeting compliance standards, we ensure your project is primed for success, minimizing the risk of costly revisions or delays.

Allied

access to global CDMO resources

Our partnership with Bora Pharmaceuticals provides additional resources and insights. This network enables us to leverage shared knowledge and expertise, further mitigating risks and accelerating the overall success of your project.